Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Merck & Co.
Pharma
AACR: Keytruda delivers an industry first in head and neck cancer
While Keytruda stands to become a new standard of care in resectable head and neck cancer, some questions remain.
Angus Liu
Apr 28, 2025 1:28pm
Summit stock falls as Akeso shares bispecific OS data vs. Keytruda
Apr 25, 2025 4:02pm
Enhertu, Akeso, Fujifilm-Regeneron—Fierce Pharma Asia
Apr 25, 2025 8:45am
Halozyme sues Merck over subcutaneous Keytruda
Apr 24, 2025 2:41pm
Gilead's Trodelvy-Keytruda proposal hits goal in first-line TNBC
Apr 21, 2025 11:29am
COVID, HPV vaccine policies poised to change per CDC panel
Apr 16, 2025 11:32am
